HUTCHMED (China) Ltd HMDCF:OTCPK

RT Quote | Exchange | USD
Last | 09/26/22 EDT
1.85UNCH (UNCH)
Volume
1
52 week range
1.80 - 2.55
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.85
  • 52 Week High2.55
  • 52 Week High Date09/14/22
  • 52 Week Low1.80
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap1,460.5M
  • Shares Out864.58M
  • 10 Day Average Volume88,461.17
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.85
  • 52 Week High2.55
  • 52 Week High Date09/14/22
  • 52 Week Low1.80
  • 52 Week Low Date09/26/22
  • Market Cap1,460.5M
  • Shares Out864.58M
  • 10 Day Average Volume88,461.17
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On HUTCHMED (China) Ltd

 

Profile

MORE
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering...
Chi Keung To
Executive Chairman of the Board
Weiguo Su Ph.D.
Chief Executive Officer, Chief Scientific Officer, Executive Director
Marek Kania
Executive President, Managing Director, Chief Medical Officer
Karen Atkin
Chief Operating Officer, Executive Vice President
Chig Fung Cheng
Chief Financial Officer, Executive Director
Address
48Th Floor, Cheung Kong Center
2 Queen's Road Central
Hong Kong